Today: 9 June 2026
Venture Global Stock Price in Focus After Qatar LNG Shock Drives Scramble for U.S. Supply
20 March 2026
2 mins read

Venture Global Stock Price in Focus After Qatar LNG Shock Drives Scramble for U.S. Supply

NEW YORK, March 20, 2026, 09:25 (EDT)

Venture Global was trading near $14.3 in Friday’s premarket, steady after a wild Thursday that saw the stock surge up to 13%. QatarEnergy had revealed Iranian strikes sidelined close to 20% of Qatar’s LNG export operations, fueling expectations that U.S. players could step in to fill the gap.

Pressure is mounting. On Friday, Italy reported it’s in discussions with the United States, Azerbaijan, and Algeria to make up for the drop in Qatari gas. Over in India, an oil ministry official warned that any reduction from Qatar would impact the country as well.

QatarEnergy chief Saad al-Kaabi told Reuters the hit would knock out 12.8 million metric tons a year of LNG production for anywhere from three to five years, and the company will have to cut back on some long-term supply contracts. Qatar tops the global LNG export rankings, just ahead of the U.S. Venture Global is notable for holding onto roughly 30% of its output for spot sales—those are cargoes priced at market rates, not locked in through lengthy agreements.

Buyers are already changing tack. “With 90 million metric tons from the Middle East absent from the global LNG market, the longer this persists, the greater the impact,” said JERA executive Ryosuke Tsugaru. He warned that if the crisis drags on, demand could swing toward U.S. and Canadian supplies. Japan’s largest power producer, Tsugaru added, is looking at picking up more spot cargoes. Reuters

Venture Global kept moving forward, even before the latest disruption. On March 13, the company announced it had reached a final investment decision for phase 2 of its CP2 LNG project, and secured $8.6 billion in financing. That brings total funding for CP2 to $20.7 billion. Venture Global says this project will put it at the top among U.S. LNG exporters once everything is up and running.

Other names followed suit. Cheniere surged to an all-time high on Thursday. Columbia University’s Ira Joseph noted that while some of the missing Qatari cargoes might get replaced by new U.S. supply coming from Sempra and NextDecade, his main concern was the North Field expansion in Qatar. “If it is impacted, then structurally we have to adjust our LNG prices higher,” Joseph said. Reuters

Venture Global’s stock had been on a tear, soaring over 87% for the year by March 3. That jump came after a New York court tossed out Shell’s attempt to reverse an arbitration win for Venture Global. The day before, the company reported that quarterly adjusted core profit had nearly tripled, thanks to stronger LNG sales volumes.

This isn’t a straightforward trade. Chief Executive Mike Sabel, speaking last week, dismissed the latest LNG price swings as “very short-term.” Yet, in a separate arbitration, BP is pressing for at least $3.7 billion in damages—possibly north of $6 billion once fees and interest get tacked on, according to a filing. Reuters market data indicate Venture Global finished 2025 carrying $34.5 billion in total debt. If the Gulf crisis fades, or legal risks resurface, there’s still plenty for investors to fret about. Reuters

Stock Market Today

  • Designer Brands (DBI) Beats Q1 Earnings and Revenue Estimates
    June 9, 2026, 10:04 AM EDT. Designer Brands (DBI) reported Q1 earnings of $0.07 per share, surpassing the Zacks estimate of $0.02 and reversing a year-ago loss of $0.26. Revenue hit $696.35 million, just above the $696 million consensus. The company delivered a 250% earnings surprise and has beaten EPS estimates in four consecutive quarters. Shares rose about 19.5% year-to-date, outpacing the S&P 500's 8.2% gain. Despite strong results, the stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market. The Retail - Apparel and Shoes sector ranks among the top three industries. Future stock performance will depend on management's outlook and upcoming earnings estimate revisions, with current consensus estimates at $0.30 EPS on $744 million revenue next quarter and $0.35 EPS on $2.91 billion revenue for the fiscal year.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
FTC Sends More Than $58 Million to Invitation Homes Renters, Credit Repair Victims
Previous Story

FTC Sends More Than $58 Million to Invitation Homes Renters, Credit Repair Victims

Denison Mines Stock Price Falls Again as Phoenix Uranium Mine Moves Into Build Phase
Next Story

Denison Mines Stock Price Falls Again as Phoenix Uranium Mine Moves Into Build Phase

Go toTop